Navigation Links
ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
Date:3/31/2009

ATHENS, Ga., March 31 /PRNewswire/ -- ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has been awarded a Department of Defense contract to develop an environmental biosensor utilizing its human stem cell technology.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO)

The company will further develop a human embryonic stem cell derived cellular model for use in a prototype biosensor developed by the Naval Research Laboratory and previously studied by the University of Georgia. Current cell sources have a limited lifespan in the field requiring frequent replacement thereby reducing the efficiency and accuracy of testing environmental toxins. ArunA is well positioned to enhance the Naval Research Laboratory's work in this area by offering a robust consistent population of human cells and expanding the capability of sensor technology.

"Effective monitoring and regulation of environmental contamination remains a major challenge of great importance for both military and civilian populations," commented David Ray, ArunA CEO. "ArunA is pleased to have an opportunity to further develop a technology that could aide national security and field combat."

About ArunA Biomedical

Located in Athens, Georgia, ArunA Biomedical, Inc. is a privately held biotechnology corporation dedicated to the discovery, manufacturing and commercialization of emerging new technologies in human stem cell research for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in understanding human development and diseases. For more information, visit: www.arunabiomedical.com

This press release contains forward-looking statements regarding the company's potential impact on scientific research and collaborations with third parties. Certain conditions could alter the outcome or progress of these statements including but not limited to unexpected manufacturing issues, product performance and quality control/assurance issues. Forward-looking statements are based on the opinions, beliefs and expectations of the company or individuals quoted in the press release and the company does not assume any obligation to update these forward-looking statements if circumstances change.


'/>"/>
SOURCE ArunA Biomedical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit
2. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells
3. ArunA Biomedical, Inc. Announces Alliance with Neuromics for Distribution of Normal Human Neural Cells
4. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
5. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
6. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
7. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing
8. Collexis Connects Biomedical Researchers and Clinical Scientists with the Collexis Expert Platform for Translational Research
9. The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program
10. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
11. Environmental Tectonics Corporations BioMedical Divisions Hyperbaric Chambers Address U.S. President Obamas Initiative to Computerize Medical Records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... PBI-Gordon Corporation is pleased to announce Dave Loecke has ... 15-year career with PBI-Gordon, Dave has served in a wide variety of roles. His ... development and launch of many of PBI-Gordon’s most successful products. , “Dave has been ...
(Date:5/26/2016)... LINDEN, Mich. , May 26, 2016  Agriculture ... Des Moines, Iowa is running ... in Lake Erie and coastal ... is key to preventing this widespread issue. ... Michigan,s Upper Peninsula, developed a new, easy ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... Medistem Panama Inc. at the City of Knowledge in Panama, a ... stem cells in the US earlier this year following FDA approval of a ...
(Date:5/25/2016)... ... May 25, 2016 , ... Thailand’s Board of ... 2016 in San Francisco. Located at booth number 7301, representatives from the Thai ... and discuss the Thai biotechnology and life sciences sector. , Deputy Secretary ...
Breaking Biology Technology:
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
(Date:3/18/2016)... , March 18, 2016 --> ... of Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and ... security companies in the border security market and the continuing ... and Europe has led visiongain to ... improved success. --> defence & security companies ...
(Date:3/15/2016)... , March 15, 2016 --> ... published by Transparency Market Research "Digital Door Lock Systems Market ... 2015 - 2023," the global digital door lock systems market ... in 2014 and is forecast to grow at a CAGR ... micro, small and medium enterprises (MSMEs) across the world and ...
Breaking Biology News(10 mins):